ajovy
Teva’s Ajovy significantly reduces migraine in children and adolescents
January 12, 2026Research and Development Neurology, Teva, ajovy, migraine
Teva’s Ajovy (fremanezumab) has demonstrated significant reduction in monthly migraine and headache days in children and adolescents with episodic migraine …
Teva Pharmaceuticals shares phase 3 data for Ajovy as migraine treatment
December 6, 2023Research and Development Neurology, Teva Pharmaceuticals, ajovy, obesity
Teva Pharmaceuticals has announced data from a post hoc analysis of two phase 3 clinical studies around the effectiveness of …
Teva’s Ajovy becomes first drug of its kind available on NHS for prevention of chronic migraine
March 12, 2020Sales and Marketing NICE, Teva, ajovy, migraine, pharma
NICE has announced the authorisation of Teva’s anti-CGRP drug Ajovy (fremanezumab) for the prevention of chronic migraine in adult patients …
FDA approves Teva’s Ajovy autoinjector for treatment of migraine
January 29, 2020Research and Development, Sales and Marketing FDA, Teva, ajovy, migraine, pharma
Israeli pharma firm Teva has revealed that the FDA has chosen to award approval to its autoinjector device for the …
Teva terminates Ajovy at Phase 3 in episodic cluster headache
April 24, 2019Research and Development Teva, ajovy, headache, pharma
Israeli pharmaceutical firm Teva has announced its intention to terminate further development of its calcitonin gene-related peptide (CGRP) inhibitor Ajovy …
Teva’s Ajovy injection secures EU approval for the prevention of migraine
April 2, 2019Manufacturing and Production, Sales and Marketing EU, Europe, Teva, ajovy, migraine, pharma
Teva has announced that its calcitonin gene-related peptide (CGRP) inhibitor Ajovy (fremanezumab) has been awarded marketing authorisation by the European …
FDA greenlights Teva’s migraine drug Ajovy in two dosage options
September 20, 2018Sales and Marketing FDA, Teva, US, ajovy, migraine, pharma
Israeli drugmaker Teva has announced that its calcitonin gene-related peptide (CGRP) inhibitor Ajovy (remanezumab-vfrm) has received FDA approval as a …
Teva shares soar after migraine treatment Ajovy approval
September 17, 2018Sales and Marketing FDA, Teva, US, ajovy, approval, israel
Shares in the Israeli pharma firm Teva soared on Sunday after the announcement that the US Food and Drug Administration …
Latest content
Five Facts about cardiovascular disease
